EURO SHOCK at a glance
As the first larger clinical study of its kind, EURO SHOCK is testing a novel intervention procedure aimed at reducing the high mortality associated with cardiogenic shock and alleviating its burden on chronic heart failure.
The core aim of EURO SHOCK is to test the acute early use of an Extracorporeal Membrane Oxygenation Machine (ECMO) to improve the poor outcomes seen in patients with cardiogenic shock.
Testing acute early up-front use of ECMO
Comparing the cost-effectiveness of up-front ECMO to the costs of current standard of care
Assessing whether a system of urgent flagged transfer of unwell patients is practical